Applications

1826 – N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) testing to support management of patients with heart failure

Find out about the service or technology in application 1826 and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input, and the outcome of the application when the MSAC process is complete.

  • Status Pre-assessment
  • Type New application
  • Pre-PASC consultation Open
  • Pre-MSAC consultation Not yet started
  • Outcome Pending

Application details

Applicant

Roche Diagnostics Australia Pty Limited

Reason for application

New Medicare Benefits Schedule item

Service or technology in this application

NT-proBNP is a substance in the blood that increases when the heart is stretched or working under extra strain. Measuring NT-proBNP may help doctors decide when to start, increase, or adjust medicines for each patient. 

Medical condition this application addresses

Heart failure is a serious condition where the heart cannot pump enough blood to meet the body’s needs, or can only do so by working under high pressure. When heart failure starts suddenly or gets worse quickly, it is a medical emergency and can be life‑threatening without treatment. Doctors diagnose heart failure using symptoms such as shortness of breath, coughing or wheezing, and feeling very tired or unable to do normal activities. Tests may show changes in the heart or in blood results, including NT‑proBNP. About 70,000 people in Australia are admitted to hospital for heart failure for the first time each year, and more than half return to hospital at least once. Treatment using recommended medicines is important to reduce the chance of death or hospital readmission.

Consultation survey and deadlines

We welcome input from everyone. We are especially keen to hear from those with lived experience of the health condition, service or technology the application is addressing.   

Before providing your input, please read our Privacy Notice for MSAC consultation input to ensure you are comfortable with how we will use your input.  

The following consultation deadlines apply:

  • Pre-PASC consultation deadline: Friday 10 July 2026 11:59pm AEST
  • Pre-MSAC consultation deadline: To be confirmed

For other ways to provide input, see how to have your say.

Find out more about consultation.

Meetings to consider this application

This application will be considered at the following meetings:

  • PASC meeting: 13 to 14 August 2026
  • ESC meeting: To be confirmed
  • MSAC meeting: To be confirmed

Find out more about our meetings.

Outcome details

The outcome of this application is pending.

More information

Find out more about: